BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Protopic®: Recommendation to monitor maintenance therapy

Active substance: tacrolimus

Important information on the safety of PROTOPIC® Salbe (containing 0.03% or 0.1% tacrolimus) and recommendation to monitor maintenance therapy

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 304KB, File is accessible